Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome.

Jensen UB, Sunde L, Timshel S, Halvarsson B, Nissen A, Bernstein I, Nilbert M.

Breast Cancer Res Treat. 2010 Apr;120(3):777-82. doi: 10.1007/s10549-009-0449-3. Epub 2009 Jul 3.

PMID:
19575290
2.

Human Splicing Finder: an online bioinformatics tool to predict splicing signals.

Desmet FO, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C.

Nucleic Acids Res. 2009 May;37(9):e67. doi: 10.1093/nar/gkp215. Epub 2009 Apr 1.

3.

Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics.

Arnold S, Buchanan DD, Barker M, Jaskowski L, Walsh MD, Birney G, Woods MO, Hopper JL, Jenkins MA, Brown MA, Tavtigian SV, Goldgar DE, Young JP, Spurdle AB.

Hum Mutat. 2009 May;30(5):757-70. doi: 10.1002/humu.20936.

4.

Breast cancer immunohistochemistry can be useful in triage of some HNPCC families.

Shanley S, Fung C, Milliken J, Leary J, Barnetson R, Schnitzler M, Kirk J.

Fam Cancer. 2009;8(3):251-5. doi: 10.1007/s10689-008-9226-4. Epub 2009 Jan 4.

PMID:
19123071
5.

The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.

Watson P, Vasen HF, Mecklin JP, Bernstein I, Aarnio M, Järvinen HJ, Myrhøj T, Sunde L, Wijnen JT, Lynch HT.

Int J Cancer. 2008 Jul 15;123(2):444-9. doi: 10.1002/ijc.23508.

6.

Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR).

Chao EC, Velasquez JL, Witherspoon MS, Rozek LS, Peel D, Ng P, Gruber SB, Watson P, Rennert G, Anton-Culver H, Lynch H, Lipkin SM.

Hum Mutat. 2008 Jun;29(6):852-60. doi: 10.1002/humu.20735.

7.

Origins and prevalence of the American Founder Mutation of MSH2.

Clendenning M, Baze ME, Sun S, Walsh K, Liyanarachchi S, Fix D, Schunemann V, Comeras I, Deacon M, Lynch JF, Gong G, Thomas BC, Thibodeau SN, Lynch HT, Hampel H, de la Chapelle A.

Cancer Res. 2008 Apr 1;68(7):2145-53. doi: 10.1158/0008-5472.CAN-07-6599.

8.

Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management.

Lynch HT, Lynch JF, Lynch PM, Attard T.

Fam Cancer. 2008;7(1):27-39. Epub 2007 Nov 13. Review.

PMID:
17999161
9.

Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC).

Geary J, Sasieni P, Houlston R, Izatt L, Eeles R, Payne SJ, Fisher S, Hodgson SV.

Fam Cancer. 2008;7(2):163-72. Epub 2007 Oct 16.

PMID:
17939062
10.

Hereditary cancer syndromes.

Fostira F, Thodi G, Konstantopoulou I, Sandaltzopoulos R, Yannoukakos D.

J BUON. 2007 Sep;12 Suppl 1:S13-22. Review.

PMID:
17935271
11.

High proportion of large genomic rearrangements in hMSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families of the Basque Country.

Martínez-Bouzas C, Ojembarrena E, Beristain E, Errasti J, Viguera N, Tejada Minguéz MI.

Cancer Lett. 2007 Oct 8;255(2):295-9. Epub 2007 Jun 19.

PMID:
17582678
12.

Structure of the human MutSalpha DNA lesion recognition complex.

Warren JJ, Pohlhaus TJ, Changela A, Iyer RR, Modrich PL, Beese LS.

Mol Cell. 2007 May 25;26(4):579-92.

13.

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).

Vasen HF, Möslein G, Alonso A, Bernstein I, Bertario L, Blanco I, Burn J, Capella G, Engel C, Frayling I, Friedl W, Hes FJ, Hodgson S, Mecklin JP, Møller P, Nagengast F, Parc Y, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Wijnen J.

J Med Genet. 2007 Jun;44(6):353-62. Epub 2007 Feb 27. Review.

14.

Partial duplications of the MSH2 and MLH1 genes in hereditary nonpolyposis colorectal cancer.

Baert-Desurmont S, Buisine MP, Bessenay E, Frerot S, Lovecchio T, Martin C, Olschwang S, Wang Q, Frebourg T.

Eur J Hum Genet. 2007 Mar;15(3):383-6. Epub 2007 Jan 17.

15.

DNA mismatch repair: functions and mechanisms.

Iyer RR, Pluciennik A, Burdett V, Modrich PL.

Chem Rev. 2006 Feb;106(2):302-23. Review. No abstract available.

PMID:
16464007
16.

The genetics of HNPCC: application to diagnosis and screening.

Abdel-Rahman WM, Mecklin JP, Peltomäki P.

Crit Rev Oncol Hematol. 2006 Jun;58(3):208-20. Epub 2006 Jan 23. Review.

PMID:
16434208
17.

Breast cancer in an MSH2 gene mutation carrier.

Westenend PJ, Schütte R, Hoogmans MM, Wagner A, Dinjens WN.

Hum Pathol. 2005 Dec;36(12):1322-6.

PMID:
16311127
18.
19.

Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer.

Casey G, Lindor NM, Papadopoulos N, Thibodeau SN, Moskow J, Steelman S, Buzin CH, Sommer SS, Collins CE, Butz M, Aronson M, Gallinger S, Barker MA, Young JP, Jass JR, Hopper JL, Diep A, Bapat B, Salem M, Seminara D, Haile R; Colon Cancer Family Registry..

JAMA. 2005 Feb 16;293(7):799-809.

20.

hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients.

Apessos A, Mihalatos M, Danielidis I, Kallimanis G, Agnantis NJ, Triantafillidis JK, Fountzilas G, Kosmidis PA, Razis E, Georgoulias VA, Nasioulas G.

Br J Cancer. 2005 Jan 31;92(2):396-404.

Supplemental Content

Support Center